Related Experiment Video
Updated: Apr 18, 2026

05:32
A Detailed Protocol for Perspiration Monitoring Using a Novel, Small, Wireless Device
Published on: November 24, 2016
8.3K
Mechanisms of eccrine anidrosis. I. High level blockade
The Journal of Investigative Dermatology
|January 28, 2015
Summary
Superficial obstruction of eccrine ducts causes anidrosis (lack of sweating) in various skin conditions. Removing the stratum corneum, like with tape stripping, restores sweating by clearing these blockages.
Area of Science:
- Dermatology
- Physiology
Background:
- Anidrosis, or the absence of sweating, can stem from various dermatoses and experimental conditions.
- Superficial obstruction of the eccrine duct is identified as a common cause across these scenarios.
Purpose of the Study:
- To investigate the underlying mechanisms of eccrine duct obstruction leading to anidrosis.
- To determine the efficacy of stratum corneum removal in restoring sweat function.
Main Methods:
- Utilized Scotch Tape stripping to remove the stratum corneum in anidrotic areas.
- Histological examination to observe ductal changes after sweat stress.
- Assessed ductal obstruction via methylene blue pore pattern analysis.
Main Results:
- Sweating was restored upon removal of the stratum corneum, indicating superficial duct obstruction.
- Histology revealed ductal dilatation post-sweat stress, consistent with obstruction.
- Inability to achieve a methylene blue pore pattern confirmed functional or anatomical obstruction.
Conclusions:
- Parakeratotic plugging of eccrine ostia causes obstruction in spontaneous dermatoses.
- Protein denaturants create intraluminal casts, leading to chemically induced anidrosis.
- PAS-positive casts are a consequence, not the cause, of ductal obstruction.
More Related Videos
Related Concept Videos
Accessory Structures of the Skin: Sweat Glands
4.8K
Sweat glands or sudoriferous glands are one of the important accessory structures of the skin. They are small, coiled tubular structures located in the dermis, the middle layer of the skin. Sweat glands are responsible for producing and secreting sweat, a watery fluid that helps regulate body temperature and excrete waste products.
Sweat glands are classified as merocrine glands; that is, the secretions are excreted by exocytosis through a duct without affecting the cells of the gland. There...
Sweat glands are classified as merocrine glands; that is, the secretions are excreted by exocytosis through a duct without affecting the cells of the gland. There...
4.8K
Thermoregulation
3.4K
The human body has a sophisticated thermoregulation system that employs negative feedback mechanisms to maintain an optimal core temperature. When the core temperature drops, peripheral and central thermoreceptors send signals to the hypothalamus, activating the heat-promoting center. This center triggers several responses aimed at increasing the core temperature. First, vasoconstriction reduces the flow of warm blood from internal organs to the skin so that the heat is not lost from the skin,...
3.4K
Depolarizing Blockers: Mechanism of Action
3.7K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
3.7K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
1.3K
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
1.3K
Cholinergic Antagonists: Pharmacological Actions
2.0K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
2.0K
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
3.8K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
3.8K

